NeuroVision Announces Participation in Landmark Alzheimer’s A4 Study Evaluating Its Novel Retinal Imaging Technology

by Business Wire • 2017/02/28 • 0 Comments

SACRAMENTO, Calif.--(BUSINESS WIRE)--NeuroVision Announces Participation in Landmark Alzheimer’s A4 Study Evaluating Its Novel Retinal Imaging Technology

Full Story →

← Fastest Brain-Computer Interface Lets Severely Paralyzed Type Quickly

Researchers aim to identify cause of eye pathologies in astronauts →

Post navigation